PLoS ONE (Jan 2010)

Expression of human beta-defensins in children with chronic inflammatory bowel disease.

  • Matthias Zilbauer,
  • Andreas Jenke,
  • Gundula Wenzel,
  • Jan Postberg,
  • Andreas Heusch,
  • Alan D Phillips,
  • Gabriele Noble-Jamieson,
  • Franco Torrente,
  • Camilla Salvestrini,
  • Robert Heuschkel,
  • Stefan Wirth

DOI
https://doi.org/10.1371/journal.pone.0015389
Journal volume & issue
Vol. 5, no. 10
p. e15389

Abstract

Read online

BACKGROUND: Human beta-defensins (hBDs) are antimicrobial peptides known to play a major role in intestinal innate host defence. Altered mucosal expression of hBDs has been suggested to be implicated in chronic inflammatory bowel disease pathogenesis. However, little is known about expression of these peptides in children. METHODS: Intestinal biopsies were obtained from the duodenum (n = 88), terminal ileum (n = 90) and ascending colon (n = 105) of children with Crohn's disease (n = 26), ulcerative colitis (n = 11) and healthy controls (n = 16). Quantitative real-time (RT) PCR was performed and absolute mRNA copy numbers analyzed for hBD1-3 as well as inflammatory cytokines IL-8 and TNF-alpha. RESULTS: Significant induction of hBD2 and hBD3 was observed in the inflamed terminal ileum and ascending colon of IBD children. In the ascending colon induction of hBD2 was found to be significantly lower in children with Crohn's disease compared to ulcerative colitis. A strong correlation was found between inducible defensins hBD2 and 3 and the inflammatory cytokines IL-8 and TNF-alpha, both in the terminal ileum and ascending colon. CONCLUSION: Our study demonstrates distinct changes in hBD expression throughout the intestinal tract of children with IBD, lending further support for their potential role in disease pathogenesis.